{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:38Z","timestamp":1792785038852,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Weifang Municipal Health Commission Research Project","award":["WFWSJK-2025-322"],"award-info":[{"award-number":["WFWSJK-2025-322"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39387-6","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T19:35:06Z","timestamp":1770579306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating multi-omics analysis identifies DNA damage-related gene CLSPN as a biomarker in gastric cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Qiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"39387_CR1","doi-asserted-by":"crossref","unstructured":"Sundar, R. et al. Gastric cancer. Lancet 405(10494), 2087\u20132102 (2025).","DOI":"10.1016\/S0140-6736(25)00052-2"},{"issue":"10","key":"39387_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu, H. et al. Cancer incidence, mortality, and burden in china: a time-trend analysis and comparison with the united States and united Kingdom based on the global epidemiological data released in 2020. Cancer Commun. (Lond). 41(10), 1037\u20131048 (2021).","journal-title":"Cancer Commun. (Lond)"},{"issue":"1","key":"39387_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan, W. L. et al. Gastric cancer treatment: recent progress and future perspectives. J. Hematol. Oncol. 16(1), 57 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"20","key":"39387_CR4","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.3390\/cancers13205216","volume":"13","author":"J K\u00f6rfer","year":"2021","unstructured":"K\u00f6rfer, J. et al. Molecular targets for gastric cancer treatment and future perspectives from a clinical and translational point of view. Cancers (Basel). 13(20), 5216 (2021).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"39387_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","volume":"168","author":"A Tubbs","year":"2017","unstructured":"Tubbs, A. et al. Endogenous DNA damage as a source of genomic instability in cancer. Cell 168(4), 644\u2013656 (2017).","journal-title":"Cell"},{"issue":"1","key":"39387_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang, R. et al. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal. Transduct. Target. Ther. 6(1), 254 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11","key":"39387_CR7","first-page":"e788","volume":"5","author":"G Federica","year":"2020","unstructured":"Federica, G. et al. Targeting the DNA damage response in cancer. MedComm 5(11), e788 (2020). (2024).","journal-title":"MedComm"},{"issue":"1","key":"39387_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molcel.2020.07.026","volume":"80","author":"T Reisl\u00e4nder","year":"2020","unstructured":"Reisl\u00e4nder, T. et al. DNA damage and cancer immunotherapy: A STING in the Tale. Mol. Cell. 80(1), 21\u201328 (2020).","journal-title":"Mol. Cell."},{"issue":"7668","key":"39387_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548(7668), 466\u2013470 (2017).","journal-title":"Nature"},{"issue":"1","key":"39387_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12957-020-02042-z","volume":"18","author":"R Jia","year":"2020","unstructured":"Jia, R. et al. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis. World J. Surg. Oncol. 18(1), 268 (2020).","journal-title":"World J. Surg. Oncol."},{"key":"39387_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinf. 54, 1301\u201313033 (2016).","journal-title":"Curr. Protoc. Bioinf."},{"issue":"D1","key":"39387_CR12","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"39387_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"39387_CR14","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48(W1), W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"39387_CR15","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li, C. et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 49(W1), W242\u2013W246 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"39387_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/biom14070749","volume":"14","author":"JTFTF Wang","year":"2024","unstructured":"Wang, J. T. F. T. F. An R-Based integrative tool for decoding human transcription Factor-Target interactions. Biomolecules 14(7), 749 (2024).","journal-title":"Biomolecules"},{"issue":"13","key":"39387_CR17","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1158\/0008-5472.CAN-23-3264","volume":"84","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Single-Cell and Spatial transcriptome profiling identifies the transcription factor BHLHE40 as a driver of EMT in metastatic colorectal cancer. Cancer Res. 84(13), 2202\u20132217 (2024).","journal-title":"Cancer Res."},{"key":"39387_CR18","doi-asserted-by":"publisher","first-page":"108260","DOI":"10.1016\/j.compbiomed.2024.108260","volume":"172","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study. Comput. Biol. Med. 172, 108260 (2024).","journal-title":"Comput. Biol. Med."},{"key":"39387_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.dnarep.2017.01.003","volume":"51","author":"A Karimaian","year":"2017","unstructured":"Karimaian, A. et al. The crosstalk between Wnt\/\u03b2-catenin signaling pathway with DNA damage response and oxidative stress: implications in cancer therapy. DNA Repair. (Amst). 51, 14\u201319 (2017).","journal-title":"DNA Repair. (Amst)"},{"key":"39387_CR20","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1038\/ncomms10994","volume":"7","author":"S Jun","year":"2016","unstructured":"Jun, S. et al. LIG4 mediates Wnt signalling-induced radioresistance. Nat. Commun. 7, 10994 (2016).","journal-title":"Nat. Commun."},{"issue":"6","key":"39387_CR21","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.3390\/ijms24065252","volume":"24","author":"AP Moreno-Londo\u00f1o","year":"2023","unstructured":"Moreno-Londo\u00f1o, A. P. et al. Canonical Wnt pathway is involved in chemoresistance and cell cycle arrest induction in colon cancer cell line spheroids. Int. J. Mol. Sci. 24(6), 5252 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"39387_CR22","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Negative regulator of E2F transcription factors links cell cycle checkpoint and DNA damage repair. Proc. Natl. Acad. Sci. U. S. A. 115(16), E3837\u2013E3845 (2018).","DOI":"10.1073\/pnas.1720094115"},{"issue":"25","key":"39387_CR23","first-page":"00118","volume":"S1471-4914","author":"P Albrecht","year":"2025","unstructured":"Albrecht, P. et al. Gastric cancer: from biomarkers to functional precision medicine. Trends Mol. Med. S1471-4914(25), 00118\u201300112 (2025).","journal-title":"Trends Mol. Med."},{"issue":"4","key":"39387_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1182\/bloodadvances.2024013446","volume":"9","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. TIFAB modulates metabolic pathways in KMT2A::MLLT3-induced AML through HNF4A. Blood Adv. 9(4), 844\u2013855 (2025).","journal-title":"Blood Adv."},{"issue":"1","key":"39387_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-025-07452-z","volume":"16","author":"YH Yang","year":"2025","unstructured":"Yang, Y. H. et al. HNF4A mitigates sepsis-associated lung injury by upregulating NCOR2\/GR\/STAB1 axis and promoting macrophage polarization towards M2 phenotype. Cell. Death Dis. 16(1), 120 (2025).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"39387_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13062-024-00549-z","volume":"19","author":"H Cao","year":"2024","unstructured":"Cao, H. et al. MIR194-2HG, a MiRNA host gene activated by HNF4A, inhibits gastric cancer by regulating MicroRNA biogenesis. Biol. Direct. 19(1), 95 (2024).","journal-title":"Biol. Direct"},{"issue":"6","key":"39387_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41419-023-05868-z","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer. Cell. Death Dis. 14(6), 356 (2023).","journal-title":"Cell. Death Dis."},{"key":"39387_CR28","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Chidamide enhances the sensitivity of gastric cancer to 5-fluorouracil chemotherapy by suppressing the HDAC3\/HNF4A\/TYMS axis. Cell. Death Dis. Online (2025).","DOI":"10.1038\/s41419-025-08247-y"},{"issue":"4","key":"39387_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1097-2765(05)00092-4","volume":"6","author":"A Kumagai","year":"2000","unstructured":"Kumagai, A. et al. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in xenopus egg extracts. Mol. Cell. 6(4), 839\u2013849 (2000).","journal-title":"Mol. Cell."},{"issue":"1","key":"39387_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12967-025-06455-w","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie, Y. et al. Potential of CLSPN as a therapeutic target in melanoma: a key player in melanoma progression and tumor microenvironment. J. Transl Med. 23(1), 470 (2025).","journal-title":"J. Transl Med."},{"key":"39387_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dnarep.2017.09.002","volume":"59","author":"D Azenha","year":"2017","unstructured":"Azenha, D. et al. Claspin functions in cell homeostasis-A link to cancer? DNA Repair. (Amst). 59, 27\u201333 (2017).","journal-title":"DNA Repair. (Amst)"},{"issue":"1","key":"39387_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12575-023-00201-6","volume":"25","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers. Biol. Proced. Online. 25(1), 16 (2023).","journal-title":"Biol. Proced. Online"},{"key":"39387_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1479-5876-10-132","volume":"10","author":"M Benevolo","year":"2012","unstructured":"Benevolo, M. et al. Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix. J. Transl Med. 10, 132 (2012).","journal-title":"J. Transl Med."},{"issue":"17","key":"39387_CR34","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.febslet.2006.06.071","volume":"580","author":"LN Bennett","year":"2006","unstructured":"Bennett, L. N. et al. Regulation of Claspin degradation by the ubiquitin-proteosome pathway during the cell cycle and in response to ATR-dependent checkpoint activation. FEBS Lett. 580(17), 4176\u20134181 (2006).","journal-title":"FEBS Lett."},{"issue":"14","key":"39387_CR35","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1091\/mbc.e09-01-0092","volume":"20","author":"D Gao","year":"2009","unstructured":"Gao, D. et al. Cdh1 regulates cell cycle through modulating the claspin\/Chk1 and the Rb\/E2F1 pathways. Mol. Biol. Cell. 20(14), 3305\u20133316 (2009).","journal-title":"Mol. Biol. Cell."},{"issue":"3","key":"39387_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/febs.14594","volume":"286","author":"VAJ Smits","year":"2019","unstructured":"Smits, V. A. J. et al. Claspin-checkpoint adaptor and DNA replication factor. FEBS J. 286(3), 441\u2013455 (2019).","journal-title":"FEBS J."},{"issue":"4","key":"39387_CR37","first-page":"103345","volume":"70","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis. Curr. Res. Transl Med. 70(4), 103345 (2022).","journal-title":"Curr. Res. Transl Med."},{"issue":"2","key":"39387_CR38","doi-asserted-by":"publisher","first-page":"113935","DOI":"10.1016\/j.yexcr.2024.113935","volume":"435","author":"Z Hou","year":"2024","unstructured":"Hou, Z. et al. CLSPN actives Wnt\/\u03b2-catenin signaling to facilitate Glycolysis and cell proliferation in oral squamous cell carcinoma. Exp. Cell. Res. 435(2), 113935 (2024).","journal-title":"Exp. Cell. Res."},{"key":"39387_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2018.09.001","volume":"84","author":"G Kobayashi","year":"2019","unstructured":"Kobayashi, G. et al. Clinicopathological significance of Claspin overexpression and its association with spheroid formation in gastric cancer. Hum. Pathol. 84, 8\u201317 (2019).","journal-title":"Hum. Pathol."},{"issue":"1","key":"39387_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13059-024-03243-5","volume":"25","author":"K Stamatiou","year":"2024","unstructured":"Stamatiou, K. et al. Ki-67 is necessary during DNA replication for fork protection and genome stability. Genome Biol. 25(1), 105 (2024).","journal-title":"Genome Biol."},{"issue":"16","key":"39387_CR41","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/cells11162601","volume":"11","author":"S Moein","year":"2022","unstructured":"Moein, S. et al. SALL4: an intriguing therapeutic target in cancer treatment. Cells 11(16), 2601 (2022).","journal-title":"Cells"},{"issue":"6","key":"39387_CR42","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/PAS.0b013e318198177d","volume":"33","author":"D Cao","year":"2009","unstructured":"Cao, D. et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am. J. Surg. Pathol. 33(6), 894\u2013904 (2009).","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"39387_CR43","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/cncr.24308","volume":"115","author":"D Cao","year":"2009","unstructured":"Cao, D. et al. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 115(12), 2640\u20132651 (2009).","journal-title":"Cancer"},{"issue":"5","key":"39387_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/PAS.0000000000002358","volume":"49","author":"A Trecourt","year":"2025","unstructured":"Trecourt, A. et al. SALL4 as a useful marker for the distinction of various gestational trophoblastic disease subtypes: choriocarcinoma from other trophoblastic lesions and early complete hydatidiform mole from partial mole and nonmolar villi. Am. J. Surg. Pathol. 49(5), 417\u2013428 (2025).","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"39387_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-024-06533-9","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification. Cell. Death Dis. 15(2), 139 (2024).","journal-title":"Cell. Death Dis."},{"issue":"2","key":"39387_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41418-023-01246-6","volume":"31","author":"L Lospinoso Severini","year":"2024","unstructured":"Lospinoso Severini, L. et al. SALL4 is a CRL3 substrate that drives Sonic Hedgehog-dependent Medulloblastoma. Cell. Death Differ. 31(2), 170\u2013187 (2024).","journal-title":"Cell. Death Differ."},{"issue":"1","key":"39387_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12935-023-02985-9","volume":"23","author":"FA Abouelnazar","year":"2023","unstructured":"Abouelnazar, F. A. et al. SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4\/VEGF pathway inhibits cancer progression. Cancer Cell. Int. 23(1), 149 (2023).","journal-title":"Cancer Cell. Int."},{"key":"39387_CR48","doi-asserted-by":"crossref","unstructured":"Han, S. X. et al. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma. J. Immunol. Res. 2014, 262385 (2014).","DOI":"10.1155\/2014\/262385"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39387-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:02:53Z","timestamp":1772197373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39387-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocol was endorsed by the Ethics Committee ofSunshine Union Hospital (Approval No.: 2025032123) and adheredto the principles of the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"7789"}}